Chandan Narayan

发表

Optimization of Compound Plate Preparation to Address Precipitation Issue in Mammalian A549 Cytotoxicity Assay

Disha Awasthy, Vijayashree Gauribidanur Raghavendra Achar, S. Barde, 2016, Journal of laboratory automation.

Simple and Rapid Method To Determine Antimycobacterial Potency of Compounds by Using Autoluminescent Mycobacterium tuberculosis

N. Dhar, V. Ramachandran, V. Balasubramanian, 2014, Antimicrobial Agents and Chemotherapy.

Virus-based SELEX (viro-SELEX) allows development of aptamers targeting knotty proteins.

S. Jang, Chonsaeng Kim, Chandan Narayan, 2019, The Analyst.

Aminopyrazinamides: novel and specific GyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis.

J. Tucker, T. Balganesh, V. Sambandamurthy, 2013, ACS chemical biology.

Optimization of RNA Aptamer SELEX Methods: Improved Aptamer Transcript 3'-End Homogeneity, PAGE Purification Yield, and Target-Bound Aptamer RNA Recovery.

William H. Thiel, William H Thiel, S. Veeramani, 2021, Nucleic acid therapeutics.

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.

J. Mckinney, L. Chiarelli, N. Dhar, 2014, Journal of medicinal chemistry.

Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.

Vijay T. Ahuja, A. Srivastava, A. Narayan, 2013, Journal of medicinal chemistry.

Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.

D. Wirth, F. Gamo, Pavithra Viswanath, 2014, Journal of medicinal chemistry.

Whole cell screen based identification of spiropiperidines with potent antitubercular properties.

Vasanthi Ramachandran, Riccardo Manganelli, S. Cole, 2015, Bioorganic & medicinal chemistry letters.

Development of a Subtype-Specific Diagnostic System for Influenza Virus H3N2 Using a Novel Virus-Based Systematic Evolution of Ligands by Exponential Enrichment (Viro-SELEX).

S. Jang, Min-jung Han, Chonsaeng Kim, 2019, Journal of biomedical nanotechnology.

Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.

Anirban Ghosh, K. Mukherjee, S. Hoffner, 2014, Journal of medicinal chemistry.